Description
Product Description:
Ponatinix is an oral drug under the generic drug ponatinib and is used as a first-line treatment for patients with chronic myelogenous leukemia.
It is a third-generation Bcr-Abl tyrosine kinase inhibitor (TKI) with high potential and multiple modes of action. It is suitable for adults with chronic myelogenous leukemia (CML) in the chronic phase, accelerated phase or blast phase or Ph+ ALL. patient. Indicated, no other TKI treatment was received.
It is also indicated for use in adult patients with T315I-positive CML (chronic phase, accelerated blast phase) or T315I-positive Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).
Features:
Product Name: Ponatinix
Generic name: ponatinib
Dosage form: tablet
Available pack sizes: 60 cans
Effective dose: 45 mg
Registerable
Reviews
There are no reviews yet.